Pharmaceutical

Futura Medical and Haleon partner to commercialise Eroxon gel in US

UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.

Jul 17, 2023 - 20:00
Futura Medical and Haleon partner to commercialise Eroxon gel in US
UK-based Futura Medical has signed a deal with Haleon to commercialise its OTC erectile dysfunction gel, Eroxon, in the US.
Read the original article

Tags:

Previous Article

STAT+: After FDA nod, Better Therapeutics races to boost dwindling cash

Next Article

FDA expands Veklury’s use to Covid-19 patients with severe kidney disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: Opportunities and challenges

Launching pharmaceuticals in Belgium, the Netherlands, ...

Sep 21, 2023

Orchard secures FDA fast track designation for Hurler syndrome gene therapy

Orchard secures FDA fast track designation for Hurler s...

Dec 2, 2023

Amylyx axes ALS drug from market after Phase III failure 

Amylyx axes ALS drug from market after Phase III failure 

Apr 7, 2024